Bristol-Myers Squibb buy Daiwa Capital Markets
Start price
28.06.23
/
50%
€59.00
Target price
28.06.24
€64.04
Performance (%)
-33.56%
End price
29.06.24
€39.20
Summary
This prediction ended on 29.06.24 with a price of €39.20. The BUY prediction by Daiwa_Capital_Market for Bristol-Myers Squibb performed very badly with a performance of -33.56%. A total of €2.16 was paid as dividends for this prediction. Daiwa_Capital_Market has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bristol-Myers Squibb | 2.862% | 2.862% | 32.436% | -5.321% |
| iShares Core DAX® | 0.855% | 0.389% | 2.533% | 52.003% |
| iShares Nasdaq 100 | -0.989% | -4.400% | 25.154% | 77.536% |
| iShares Nikkei 225® | -1.781% | -11.216% | 44.398% | 64.676% |
| iShares S&P 500 | 0.057% | 0.778% | 20.953% | 63.009% |
Comments by Daiwa_Capital_Market for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) is now covered by analysts at Daiwa Capital Markets. They set an "outperform" rating and a $70.00 price target on the stock.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von Daiwa_Capital_Market gewählte maximale Laufzeit wurde überschritten